Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.42 USD | +4.86% | +8.02% | +43.55% |
02:05pm | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
05-21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
882M | - | - | - | |||
114B | ||||||
105B | ||||||
23.83B | - | |||||
21.73B | - | |||||
18.1B |
- Stock Market
- Equities
- IMNM Stock
- Charts Immunome, Inc.
- Sector Chart